FOF/PE/VC  Blue Owl

https://www.blueowl.com/





     Office Locations:

8 Newbury Street, Suite 301
Boston, MA 02116

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Middle Market


 

Industries:

  • Financial Services
  • Information Technology
  • Life Sciences & Healthcare
  • Software & Internet
  • Sports & Entertainment

  •  

    Description:

    Blue Owl (NYSE: OWL) is a leading asset manager that is redefining alternatives. With over $250 billion in assets under management as of December 31, 2024, Blue Owl invests across three multi-strategy platforms: Credit, GP Strategic Capital, and Real Assets. Anchored by a strong permanent capital base, we provide businesses with private capital solutions to drive long-term growth and offer institutional investors, individual investors, and insurance companies differentiated alternative investment opportunities that aim to deliver strong performance, risk-adjusted returns, and capital preservation. The firm provides capital to the world's leading alternative investment firms, primarily focused on acquiring minority equity stakes in established private market managers. As part of Blue Owl's established relationship with the NBA, the firm is building a diversified portfolio of minority equity investments in professional basketball teams, aiming to become the buyer of choice for selling owners. The firm's Real Assets platform has established itself as a leader in investing across asset classes and geographies, offering flexible capital solutions to tenants, borrowers, and hyperscalers.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Craig W. Packer Co-President
    Doug Ostrover Co-Chief Executive Officer
    Marc Lipschultz Co-Chief Executive Officer
    Marc Zahr Co-President
    Michael Rees Co-President

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      12/06/2024


      Nuvig Therapeutics


      CA


      $161,000,000


      Series B


      12/05/2024


      Splitero


      CA


      $350,000,000


      Credit Facility


      08/08/2024


      CloudPay


      NC


      $120,000,000


      Venture


      07/16/2024


      Cardurion Pharmaceuticals


      MA


      $260,000,000


      Series B


      06/11/2024


      AlphaSense


      NY


      $650,000,000


      Venture


      04/03/2024


      Obsidian Therapeutics


      MA


      $160,500,000


      Series C


     

    Portfolio companies include:


      6Sense
        web link


      AlphaSense
        web link


      Axonius
        web link


      Cardurion Pharmaceuticals
        web link


      CloudPay
        web link


      Nuvig Therapeutics
        web link


      Obsidian Therapeutics
        web link


      Splitero
        web link


      Vestwell
        web link


     

    Recent News: